Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Spain / NCT05592314
Recruiting Observational

Lnfluence of the Prosthetic Emergence Profile on the Prevalence of Peri-implant Diseases

NCT05592314 · tracked via the Priya Life Science Spain tracker
Sponsor
Ramón Pons Calabuig
Phase
Observational
Started
2021-05-05
Last updated
2025-03-30

Condition(s) studied

Peri-Implantitis

Investigational drug(s) / intervention(s)

No intervention

No intervention: No intervention

Study summary

1. Objectives:

To evaluate the influence of the shape and contour of implant-supported restorations on peri-implant soft and hard tissues by using an intraoral scanner.
2. Material and methods:

1. Number of patients to be treated: 120
2. Number of visits per patient: 1
3. Brief description of the different techniques used in the study, authorized and validated in the literature (3-5 lines).

A clinical and radiographic evaluation of the dental implants of those patients who are undergoing maintenance therapy treated by the Department of Periodontics of the International University of Catalonia prior to 2017 will be carried out. Additionally, a digital scan of the crown will be carried out using a intraoral scanner. Finally, patients will fill out a questionnaire about their routine dental care.
4. Benefits and harms of participating in the study for the patient

Participating in this study implies irradiating the patient through a periapical x-ray in order to assess the bone level of their implants and therefore be able to diagnose the presence or absence of peri-implant disease. Regarding the possible benefits, the patient will help the scientific community to determine the ideal contour and shape of the implant-supported restoration that will prevent the appearance of peri-implant diseases. Likewise, patients will undergo an exhaustive clinical and radiographic review that will allow their dental and periodontal status to be updated.
5. Alternative treatment in case the patient does not wish to participate in the clinical study

As this is an observational study, there is no alternative treatment. The patient will have absolute freedom to decline to participate in the study.
6. Treatment to be carried out in the event that complications arise in the patient, once the clinical study has begun

If after handling the prosthesis, it is detected that any of the screws that support the prostheses are loose or defective, the MORE department will be informed in order to replace said accessory. On the other hand, they would be informed in the same way in case of detecting any complication/alteration with the patient's implant-supported crowns.
7. Material needed to carry out the study (

To carry out this study, you will need posterior radiographic positioners, radiographs, an intraoral scanner (3Shape Trios®), the implant analogs or replicas, and a basic periodontal examination set (exploratory probe, periodontal probe, Nabers probe, mirror). and tweezers).
3. Evaluation of experimental and statistical results (3 lines) -

The data obtained will be analyzed through a descriptive statistical analysis (mean, median and standard deviations). The qualitative variables will be expressed in frequencies and percentages. In addition, logistic regression analyzes will be performed to determine the association between peri-implant status (at the implant and patient level) and the angle/emergence of implant-supported prostheses.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Patients aged 18-80 years, * Implant properly positioned (≥ 2 mm from the buccal plate and \>1 mm from the lingual plate or in the ideal occlusal plane horizontally, 5 to 2 mm from the adjacent CEJ or from 2 mm below the residual ridge to crestal position (0 mm) apico-coronally and with an angulation of 70 to 90 degrees from the adjacent tooth long axis or from the ridge parallelism) (21), * Implant loading for more than 3 years, * Partial or total edentulism being restored with dental implants in the molar and premolar region with single or partial restorations. * Patients who have not taken any antibiotic and regular NSAIDs in the last 2 months prior to the clinical examination, Exclusion Criteria: * Uncontrolled systemic diseases (i.e., diabetes mellitus) * Pregnancy or lactation patients, * Smokers of ≥10 cig/day. * Zygomatic or pterygoid implants, * Removable prostheses and cement-retained implant prostheses, * Patients who have undergone non-surgical peri-implant treatment with prosthesis modifications, peri-implantitis surgical treatment or soft tissue augmentation procedures at the implant site. * Intake of medications known to modify bone metabolism (i.e., hyperparathyroidism, osteoporosis, and vitamin D deficiency), * Uncontrolled or active periodontal disease that required treatment.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Universitat Internacional de Catalunya Sant Cugat del Vallès Barcelona Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05592314 on ClinicalTrials.gov ↗ ← All trials in Spain